Inventor · disambiguated record
Christopher D. Thanos
Also filed as: THANOS CHRISTOPHER · THANOS CHRISTOPHER D
48 granted patents·23 pending applications·311 citations·filing 2005–2025
98Inventor score
Files withSUTRO BIOPHARMA INC33ACTYM THERAPEUTICS INC14MADISON EDWIN L8CATALYST BIOSCIENCES INC6HALOZYME INC3
Top patents by PatentIndex Score
71 records- 0197US9682934B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2013·Granted Jun 20, 2017·35 cites·35 claims
- 0295US10112900B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·12 cites·13 claims
- 0395US9988619B2Non-natural amino acid tRNA synthetases for pyridyl tetrazineSUTRO BIOPHARMA INC·Filed 2014·Granted Jun 5, 2018·40 cites·10 claims
- 0494US9938516B2Non-natural amino acid tRNA synthetases for para-methylazido-L-phenylalanineSUTRO BIOPHARMA INC·Filed 2014·Granted Apr 10, 2018·40 cites·22 claims
- 0594US9764039B2Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2014·Granted Sep 19, 2017·20 cites·36 claims
- 0693US10450353B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2017·Granted Oct 22, 2019·6 cites·13 claims
- 0793US8778870B2Modified factor IX polypeptides and uses thereofMADISON EDWIN L·Filed 2011·Granted Jul 15, 2014·24 cites·37 claims
- 0892US10774354B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2018·Granted Sep 15, 2020·9 cites·29 claims
- 0992US10669347B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·5 cites·16 claims
- 1092US9738724B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 22, 2017·12 cites·35 claims
- 1191US10190145B2Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expressionSUTRO BIOPHARMA INC·Filed 2014·Granted Jan 29, 2019·12 cites·20 claims
- 1291US10179909B2Non-natural amino acid tRNA synthetases for pyridyl tetrazineSUTRO BIOPHARMA INC·Filed 2018·Granted Jan 15, 2019·5 cites·10 claims
- 1391US9994527B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2017·Granted Jun 12, 2018·6 cites·15 claims
- 1491US9732161B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2013·Granted Aug 15, 2017·7 cites·20 claims
- 1591US8519103B2Factor VII polypeptides that are modified and uses thereofMADISON EDWIN L·Filed 2009·Granted Aug 27, 2013·16 cites·71 claims
- 1690US11261219B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 1, 2022·4 cites·15 claims
- 1789US11779612B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Oct 10, 2023·3 cites·60 claims
- 1889US11168326B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·5 cites·38 claims
- 1989US10730837B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·27 claims
- 2089US9650621B2Proteolytic inactivation of select proteins in bacterial extracts for improved expressionSUTRO BIOPHARMA INC·Filed 2013·Granted May 16, 2017·10 cites·13 claims
- 2188US12269801B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2022·Granted Apr 8, 2025·0 cites·17 claims
- 2288US11548852B2Modified amino acidsSUTRO BIOPHARMA INC·Filed 2020·Granted Jan 10, 2023·1 cites·26 claims
- 2388US11242528B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·3 cites·35 claims
- 2488US10501558B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·20 claims
- 2588US9476037B2Factor VII polypeptides that are modified and uses thereofCATALYST BIOSCIENCES INC·Filed 2013·Granted Oct 25, 2016·8 cites·30 claims
- 2684US12024709B2Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 2, 2024·2 cites·47 claims
- 2784US9795655B2Modified MT-SP1 proteases that inhibit complement activationMADISON EDWIN L·Filed 2014·Granted Oct 24, 2017·7 cites·12 claims
- 2884US2025236594A1Modified amino acidsSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2983US11958909B2Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2020·Granted Apr 16, 2024·1 cites·20 claims
- 3083US11203749B2Factor VII polypeptides that are modified and uses thereofCATALYST BIOSCIENCES INC·Filed 2018·Granted Dec 21, 2021·1 cites·6 claims
- 3183US2025002604A1Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3281US10160961B2Factor VII polypeptides that are modified and uses thereofCATALYST BIOSCIENCES INC·Filed 2016·Granted Dec 25, 2018·2 cites·26 claims
- 3381US9328339B2Modified factor IX polypeptides and uses thereofMADISON EDWIN L·Filed 2014·Granted May 3, 2016·4 cites·30 claims
- 3480US12226439B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·41 claims
- 3580US2025345369A1Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3679US12201653B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Jan 21, 2025·0 cites·29 claims
- 3778US2023203470A1Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using sameHALOZYME INC·Filed 2022·Application pending·0 cites
- 3877US9896685B2Use of LAMBDA-GAM protein in ribosomal display technologySUTRO BIOPHARMA INC·Filed 2014·Granted Feb 20, 2018·1 cites·9 claims
- 3974US12331334B2Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·0 cites·65 claims
- 4074US9969998B2Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using sameHALOZYME INC·Filed 2016·Granted May 15, 2018·1 cites·43 claims
- 4174US2025304723A1Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 4272US12252552B2Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2019·Granted Mar 18, 2025·0 cites·32 claims
- 4372US2023114070A1Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their useSUTRO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4471US12357661B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·37 claims
- 4571US12012600B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·0 cites·32 claims
- 4671US10975150B2Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodiesSUTRO BIOPHARMA INC·Filed 2015·Granted Apr 13, 2021·1 cites·29 claims
- 4770US11584923B2Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using sameHALOZYME INC·Filed 2018·Granted Feb 21, 2023·0 cites·53 claims
- 4870US2021230570A1Modified factor ix polypeptides and uses thereofCATALYST BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 4968US10731148B2Use of lambda-gam protein in ribosomal display technologySUTRO BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·0 cites·6 claims
- 5066US8129186B2Choroid plexus preparation and uses thereofELLIOTT ROBERT BARTLETT·Filed 2006·Granted Mar 6, 2012·1 cites·19 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Christopher D. Thanos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →